Cargando…
CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441960/ http://dx.doi.org/10.1186/1742-4690-9-S2-P351 |
| _version_ | 1782243409557192704 |
|---|---|
| author | Katinger, D Jeffs, S Altmann, F Cope, A McKay, P Almond, N Sandström, E Hejdeman, B Biberfeld, G Nilsson, C Hallengärd, D Wahren, B Lehner, T Singh, M Lewis, DJ Lacey, C Shattock, R |
| author_facet | Katinger, D Jeffs, S Altmann, F Cope, A McKay, P Almond, N Sandström, E Hejdeman, B Biberfeld, G Nilsson, C Hallengärd, D Wahren, B Lehner, T Singh, M Lewis, DJ Lacey, C Shattock, R |
| author_sort | Katinger, D |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3441960 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2012 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-34419602012-09-18 CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization Katinger, D Jeffs, S Altmann, F Cope, A McKay, P Almond, N Sandström, E Hejdeman, B Biberfeld, G Nilsson, C Hallengärd, D Wahren, B Lehner, T Singh, M Lewis, DJ Lacey, C Shattock, R Retrovirology Poster Presentation BioMed Central 2012-09-13 /pmc/articles/PMC3441960/ http://dx.doi.org/10.1186/1742-4690-9-S2-P351 Text en Copyright ©2012 Katinger et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Katinger, D Jeffs, S Altmann, F Cope, A McKay, P Almond, N Sandström, E Hejdeman, B Biberfeld, G Nilsson, C Hallengärd, D Wahren, B Lehner, T Singh, M Lewis, DJ Lacey, C Shattock, R CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization |
| title | CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization |
| title_full | CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization |
| title_fullStr | CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization |
| title_full_unstemmed | CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization |
| title_short | CN54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for HIV immunization |
| title_sort | cn54gp140: product characteristics, peclinical and clinical use - recombinant glycoprotein for hiv immunization |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441960/ http://dx.doi.org/10.1186/1742-4690-9-S2-P351 |
| work_keys_str_mv | AT katingerd cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT jeffss cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT altmannf cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT copea cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT mckayp cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT almondn cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT sandstrome cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT hejdemanb cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT biberfeldg cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT nilssonc cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT hallengardd cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT wahrenb cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT lehnert cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT singhm cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT lewisdj cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT laceyc cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization AT shattockr cn54gp140productcharacteristicspeclinicalandclinicaluserecombinantglycoproteinforhivimmunization |